0%
0 / 15 answered
Adverse Drug Event Reporting Practice Test
•15 QuestionsQuestion
1 / 15
Q1
A 27-year-old female (60 kg) is started on isotretinoin 40 mg by mouth twice daily for severe acne through a risk management program. Current medications: combined oral contraceptive (ethinyl estradiol/norgestimate) 1 tablet by mouth daily, multivitamin 1 tablet by mouth daily. Allergies: none known. Medical history: acne vulgaris. Baseline labs: aspartate aminotransferase 28 units/L (normal), alanine aminotransferase 30 units/L (normal), triglycerides 180 mg/dL (high; normal <150 mg/dL), serum pregnancy test negative. Which monitoring parameter is critical for this patient on isotretinoin?
A 27-year-old female (60 kg) is started on isotretinoin 40 mg by mouth twice daily for severe acne through a risk management program. Current medications: combined oral contraceptive (ethinyl estradiol/norgestimate) 1 tablet by mouth daily, multivitamin 1 tablet by mouth daily. Allergies: none known. Medical history: acne vulgaris. Baseline labs: aspartate aminotransferase 28 units/L (normal), alanine aminotransferase 30 units/L (normal), triglycerides 180 mg/dL (high; normal <150 mg/dL), serum pregnancy test negative. Which monitoring parameter is critical for this patient on isotretinoin?